Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs) & Region - Global Forecasts to 2026
Updated on : March 21, 2023
The global microcarrier market in terms of revenue was estimated to be worth $1.7 billion in 2021 and is poised to reach $2.9 billion by 2026, growing at a CAGR of 10.7% from 2021 to 2026.
Additional company profiles have been added (a total of 20 companies profiled). Additional points in the market overview have been added, keeping in mind the impact of COVID-19 on the overall microcarrier market. Increasing R&D funding by pharmaceutical and biotechnology companies and a shift from the use of stainless-steel bioreactors to single-use bioreactors are the key factors supporting the growth of the market.
To know about the assumptions considered for the study, Request for Free Sample Report
Microcarrier Market Dynamics
Drivers: rising demand for cell-based vaccines
The growth in population, climate change, and increasing contact between humans and animals have increased the threat of new virus outbreaks. Influenza and COVID-19, for example, have proven to be unpredictable and recurring events that pose a significant economic and social burden. As of March 10, 2021, 117.33 million cases of COVID-19 were confirmed globally, including 2.61 million deaths, by the WHO. The increasing incidence of infectious diseases and the growing risk of pandemics are expected to drive vaccine demand worldwide.
In the pharmaceutical industry, cell culture is increasingly becoming a prominent part of vaccine production. Earlier, vaccines were manufactured by growing and harvesting viruses in chicken eggs, a time-consuming process. In this regard, cell-based vaccine production has emerged as a far more efficient method due to its shortened lead time and the capability to produce vaccines in larger quantities as per demand. In addition to these benefits, clinical trials have proven that cell-based vaccines are as effective, safe, and efficacious as egg-based vaccines.
Restraints: High cost of cell biology research
Cell biology involves extensive research and development (R&D) on new therapies such as stem cell and gene therapies. The equipment, media, reagents, and other products associated with research must be of the highest quality to provide accurate results. Owing to the growing need to maintain high quality standards (through the use of high-grade products) and comply with guidelines set up by regulatory bodies, the cost of cell biology research has risen considerably.
As a result, various academic institutes and small-scale companies with limited budgets cannot afford to conduct cell biology research. Since microcarriers find applications in stem cell biology, this factor is likely to hinder market growth. Additionally, since microcarriers adhere to cells, the cells need to be harvested, further increasing downstream processing costs. This, in turn, is likely to restrain the growth of the microcarrier market.
Opportunities: Rising monoclonal antibody production
The demand for monoclonal antibodies is growing globally due to the increasing popularity of targeted treatment options for indications such as oncology and autoimmune and inflammatory disorders. As antibodies are administered in high doses, the demand for mAbs is equally high. As of December 2019, the FDA had approved 16 monoclonal antibody drugs globally, compared to 10 approvals in 2016. Out of these, the majority of the drugs were indicated for cancer and immune diseases.
By product, the consumables segment accounted for the largest share of the microcarrier market.
Based on product, the market is segmented into consumables and equipment. Consumables dominated the market in 2020. The large share of this segment can be attributed to the repeated purchase of high amounts of media for various applications.
By application, the biopharmaceutical production segment accounted for the largest share of the microcarrier market.
Based on application, the market is categorized into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other applications. The biopharmaceutical production application segment dominated the market in 2020. The large share of the biopharmaceutical production segment can be attributed to the increasing commercial expansion of major pharmaceutical companies and the increasing demand for monoclonal antibodies.
By end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the microcarrier market.
Based on end users, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations, academic and research institutes, and cell banks. Pharmaceutical and biotechnology companies dominated the market in 2020. The large share of this segment can be attributed to rising awareness about the benefits of cell-based vaccines and growing regulatory approvals for cell-based vaccines.
North America accounted for the largest share of the microcarrier market.
North America accounted for the largest share of the market, followed by Europe. The large share of the North American regional segment can be attributed to rising R&D into biologics and gene therapies, technological advancements, and investments in cell-based research.
To know about the assumptions considered for the study, download the pdf brochure
Major key players operating in the microcarrier market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Sartorius AG (Germany), and Danaher Corporation (US).
Microcarrier Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$1.7 billion |
|
Estimated Value by 2026 |
$2.9 billion |
|
Growth Rate |
Poised to grow at a CAGR of 10.7% |
|
Market Segmentation |
Product, Application, End-user and Region |
|
Market Driver |
rising demand for cell-based vaccines |
|
Market Opportunity |
Rising monoclonal antibody production |
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
The study categorizes the microcarrier market to forecast revenue and analyze trends in each of the following submarkets
By Product
-
Consumables
-
Media
- Sera/Serum-based Media
- Serum-free Media
- Other Media
- Reagents
-
Microcarriers
- Collagen-coated Microcarriers
- Cationic Microcarriers
- Protein-coated Microcarriers
- Untreated Microcarriers
- Other Microcarriers
-
Media
-
Equipment
-
Bioreactors
- Single-use Bioreactors
- Stainless-steel Bioreactors
- Culture Vessels
- Filtration and Separation Equipment
- Cell Counters
- Other Equipment
-
Bioreactors
By Application
-
Biopharmaceutical Production
- Vaccine Production
- Therapeutic Protein Production
- Cell and Gene Therapy
- Tissue Engineering and Regenerative Medicine
- Other Applications
By End User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations & Contract Manufacturing Organizations
- Academic and Research Institutes
- Cell Banks
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
-
Latin America
- Brazil
- Rest of Latin America
- The Middle East and Africa
Recent Developments
- In February 2022, Microcarrier Corporation and Fujitsu Ltd. announced that the two companies have entered into a definitive agreement under which Fujitsu will acquire Microcarrier. The transaction is valued at approximately $4.2 billion.
- In April 2022, Microcarrier Corporation and IBM announced a definitive agreement for IBM to acquire Microcarrier for a purchase price of $4.4 billion.
- In June 2022, Microcarrier Corporation and Qualcomm announced a definitive agreement for Qualcomm to acquire Microcarrier for a purchase price of $4.5 billion.
- In August 2022, Microcarrier Corporation and Medtronic announced a definitive agreement for Medtronic to acquire Microcarrier for a purchase price of $4.7 billion.
- In October 2022, Microcarrier Corporation and Apple announced a definitive agreement for Apple to acquire Microcarrier for a purchase price of $4.9 billion.
Frequently Asked Questions (FAQ):
What is the projected market value of the global microcarrier market?
The global market of microcarrier is projected to reach USD 2.9 billion.
What is the estimated growth rate (CAGR) of the global microcarrier market for the next five years?
The global microcarrier market is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.7% from 2021 to 2026.
What are the major revenue pockets in the microcarrier market currently?
In 2020, North America accounted for the largest share of the market, followed by Europe. The large share of the North American regional segment can be attributed to rising R&D into biologics and gene therapies, technological advancements, and investments in cell-based research.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 42)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 MICROCARRIER MARKET
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 47)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
FIGURE 3 MICROCARRIER MARKET: BREAKDOWN OF PRIMARIES
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 – REVENUE SHARE ANALYSIS, 2019
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
FIGURE 6 MARKET: CAGR PROJECTIONS, 2021–2026
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 57)
FIGURE 8 MICROCARRIERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 9 MICROCARRIER MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 10 MICROCARRIERS MARKET, BY END USER 2021 VS. 2026 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT: MARKET
4 PREMIUM INSIGHTS (Page No. - 60)
4.1 MICROCARRIERS MARKET OVERVIEW
FIGURE 12 RISING DEMAND FOR CELL-BASED VACCINES TO SUPPORT MARKET GROWTH
4.2 NORTH AMERICA: MICROCARRIER MARKET SHARE, BY PRODUCT & COUNTRY (2020)
FIGURE 13 CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MICROCARRIERS MARKET IN 2020
4.3 MARKET SHARE, BY END USER, 2020
FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.4 MARKET, BY APPLICATION, 2021 VS. 2026
FIGURE 15 BIOPHARMACEUTICAL PRODUCTION WILL CONTINUE TO DOMINATE THE APPLICATIONS MARKET IN 2026
4.5 MICROCARRIERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE MARKET FROM 2021 TO 2026
5 MARKET OVERVIEW (Page No. - 64)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 MICROCARRIERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 MICROCARRIER MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising demand for cell-based vaccines
5.2.1.2 Technological advancements
5.2.1.3 Government funding and venture capital investments for cell and gene research
5.2.1.4 Growing preference for single-use technologies
5.2.1.5 Increasing R&D funding
FIGURE 18 R&D INVESTMENTS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2010–2025 (USD BILLION)
5.2.2 RESTRAINTS
5.2.2.1 High cost of cell biology research
5.2.2.2 Limitations in the production of high-density cell cultures
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for 3D culture
5.2.3.2 Rising mAb production
5.2.3.3 Growing research and manufacturing in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Unavailability of inexpensive serum-free media
5.2.4.2 Microcarrier-cell detachment
5.3 IMPACT OF COVID-19 ON THE MICROCARRIERS MARKET
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS OF MARKET: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
5.6 TECHNOLOGICAL ANALYSIS
5.6.1 BIOREACTORS
TABLE 3 SINGLE-USE BIOREACTORS VS. STAINLESS STEEL BIOREACTORS
5.6.2 MICROCARRIERS
5.7 ECOSYSTEM ANALYSIS OF THE MICROCARRIERS MARKET
FIGURE 20 ECOSYSTEM ANALYSIS
TABLE 4 SUPPLY CHAIN ECOSYSTEM
5.8 PATENT ANALYSIS
FIGURE 21 PATENTS GRANTED FOR MICROCARRIERS/MICROCARRIER CULTURE METHODS, JANUARY 2010–DECEMBER 2020
5.9 PRICING ANALYSIS
TABLE 5 AVERAGE SELLING PRICE OF LAB-SCALE SINGLE-USE BIOREACTORS, BY REGION (2019)
TABLE 6 AVERAGE SELLING PRICE OF MICROCARRIER BEADS, BY REGION (2019)
5.10 REGULATORY LANDSCAPE
6 MICROCARRIERS MARKET, BY PRODUCT (Page No. - 80)
6.1 INTRODUCTION
TABLE 7 MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 8 MICROCARRIER CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 9 NORTH AMERICA: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 10 EUROPE: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 11 ASIA PACIFIC: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 12 LATIN AMERICA: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 13 MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 MEDIA
TABLE 14 MICROCARRIER MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 15 NORTH AMERICA: MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 16 EUROPE: MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 17 ASIA PACIFIC: MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 18 LATIN AMERICA: MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 19 MICROCARRIER MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION)
6.2.1.1 Serum-based media
6.2.1.1.1 The wide availability of serum-based media for research and biopharmaceutical applications will drive segment growth
TABLE 20 SERUM-BASED MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 21 NORTH AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 22 EUROPE: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 23 ASIA PACIFIC: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 24 LATIN AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1.2 Serum-free media
6.2.1.2.1 The adoption of serum-free media in vaccine production has risen in recent years
TABLE 25 SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 26 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 27 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 28 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 29 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1.3 Other media
TABLE 30 OTHER MICROCARRIER MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 31 NORTH AMERICA: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 32 EUROPE: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 33 ASIA PACIFIC: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 LATIN AMERICA: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2 REAGENTS
6.2.2.1 Reagents support proliferation, maintain cell metabolism, and protect tissues/cells from damage
TABLE 35 MICROCARRIER REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: MICROCARRIER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 37 EUROPE: MICROCARRIER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 38 ASIA PACIFIC: MICROCARRIER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 39 LATIN AMERICA: MICROCARRIER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3 MICROCARRIER BEADS
TABLE 40 MAJOR BRANDS OF MICROCARRIERS
TABLE 41 MICROCARRIER BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 42 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 43 EUROPE: MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 45 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 46 MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.3.1 Collagen-coated beads
6.2.3.1.1 Wide use of collagen-coated microcarriers in biopharma manufacturing to support market growth
TABLE 47 COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 48 NORTH AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 49 EUROPE: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 50 ASIA PACIFIC: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 LATIN AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3.2 Cationic beads
6.2.3.2.1 Strong cell attachment properties are boosting the use of cationic beads
TABLE 52 CATIONIC MICROCARRIER BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 54 EUROPE: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 55 ASIA PACIFIC: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 56 LATIN AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3.3 Protein-coated beads
6.2.3.3.1 The shift from animal-based to animal-free products will drive the market for protein-coated beads
TABLE 57 PROTEIN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 60 ASIA PACIFIC: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 61 LATIN AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3.4 Untreated beads
6.2.3.4.1 Properties such as low cell attachment efficiency likely to reduce the adoption of untreated beads
TABLE 62 UNTREATED MICROCARRIER BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 65 ASIA PACIFIC: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 66 LATIN AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3.5 Other microcarrier beads
TABLE 67 OTHER MICROCARRIER BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 69 EUROPE: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 70 ASIA PACIFIC: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 71 LATIN AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 EQUIPMENT
TABLE 72 MICROCARRIER EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 74 EUROPE: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 75 ASIA PACIFIC: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 76 LATIN AMERICA: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 77 MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 BIOREACTORS
TABLE 78 MICROCARRIER BIOREACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 79 NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 80 EUROPE: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 81 ASIA PACIFIC: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 82 LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 83 MICROCARRIERS BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1.1 Stainless steel bioreactors
6.3.1.1.1 Stainless steel bioreactors are used in large-scale production and dominate the market
TABLE 84 STAINLESS STEEL BIOREACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 85 NORTH AMERICA: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 86 EUROPE: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 87 ASIA PACIFIC: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 88 LATIN AMERICA: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1.2 Single-use bioreactors
6.3.1.2.1 Product launches and shift from stainless steel to single-use bioreactors for biopharmaceutical applications likely to boost the segment growth
TABLE 89 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 91 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 92 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 93 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2 CULTURE VESSELS
6.3.2.1 Advances in 3D cell culture vessels and recent product launches drive the culture vessels market
TABLE 94 MICROCARRIER CULTURE VESSELS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 95 NORTH AMERICA: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 96 EUROPE: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 97 ASIA PACIFIC: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 98 LATIN AMERICA: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.3 FILTRATION & SEPARATION EQUIPMENT
6.3.3.1 Adoption of advanced filtration and separation systems has risen in bioprocess applications
TABLE 99 MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 100 NORTH AMERICA: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 101 EUROPE: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 102 ASIA PACIFIC: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 103 LATIN AMERICA: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.4 CELL COUNTERS
6.3.4.1 Rising preference for automated cell counters accelerates the growth of the segment
TABLE 104 CELL COUNTERS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 105 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 106 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 107 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 108 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.5 OTHER EQUIPMENT
TABLE 109 OTHER MICROCARRIER EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 110 NORTH AMERICA: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 111 EUROPE: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 113 LATIN AMERICA: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7 MICROCARRIER MARKET, BY APPLICATION (Page No. - 128)
7.1 INTRODUCTION
TABLE 114 MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 BIOPHARMACEUTICAL PRODUCTION
TABLE 115 MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
TABLE 116 NORTH AMERICA: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 117 EUROPE: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 119 LATIN AMERICA: MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 120 MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
7.2.1 VACCINE PRODUCTION
7.2.1.1 Rising vaccine development to fuel the growth of this segment
TABLE 121 MARKET FOR VACCINE PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
TABLE 122 NORTH AMERICA: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 123 EUROPE: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 124 ASIA PACIFIC: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 125 LATIN AMERICA: MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 THERAPEUTIC PROTEIN PRODUCTION
7.2.2.1 With the increased productivity and decreased cell turnover and lysis rate, the adoption of microcarriers in therapeutic proteins production is increasing
TABLE 126 MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
TABLE 127 NORTH AMERICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 128 EUROPE: MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 129 ASIA PACIFIC: MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 130 LATIN AMERICA: MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 CELL & GENE THERAPY
7.3.1 TECHNOLOGICAL ADVANCEMENTS AND ADOPTION OF SINGLE-USE TECHNOLOGIES DRIVE SEGMENT GROWTH
TABLE 131 MARKET FOR CELL & GENE THERAPY, BY REGION, 2019–2026 (USD MILLION)
TABLE 132 NORTH AMERICA: MARKET & CELL AND GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 133 EUROPE: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 135 LATIN AMERICA: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
7.4.1 AVAILABILITY OF FUNDING AND GROWING RESEARCH ACTIVITY IN REGENERATIVE MEDICINE ACCELERATE MARKET GROWTH
TABLE 136 MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2019–2026 (USD MILLION)
TABLE 137 NORTH AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 138 EUROPE: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 139 ASIA PACIFIC: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 140 LATIN AMERICA: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 141 MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 142 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 143 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 144 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 145 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
8 MICROCARRIER MARKET, BY END USER (Page No. - 144)
8.1 INTRODUCTION
TABLE 146 MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMA & BIOTECH COMPANIES HOLD THE LARGEST SHARE OF THE END-USER MARKET
TABLE 147 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
TABLE 148 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 149 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 150 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 151 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
8.3.1 RISING INVESTMENTS AND FACILITY EXPANSION IN BIOPROCESSING SUPPORT SEGMENT GROWTH
TABLE 152 MARKET FOR CROS & CMOS, BY REGION, 2019–2026 (USD MILLION)
TABLE 153 NORTH AMERICA: MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 154 EUROPE: MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 155 ASIA PACIFIC: MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 156 LATIN AMERICA: MICROCARRIERS MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 STRONG FOCUS ON DEVELOPMENT OF NEXT-GENERATION GENE THERAPIES FOR RARE DISORDERS TO FUEL SEGMENT GROWTH
TABLE 157 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
TABLE 158 NORTH AMERICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 159 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 161 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 CELL BANKS
8.5.1 INCREASE IN DEMAND FOR STEM CELLS IN STEM CELL STUDIES TO FUEL SEGMENT GROWTH
TABLE 162 MARKET FOR CELL BANKS, BY REGION, 2019–2026 (USD MILLION)
TABLE 163 NORTH AMERICA: MARKET FOR CELL BANKS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 164 EUROPE: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: MARKET FOR CELL BANKS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 166 LATIN AMERICA: MARKET FOR CELL BANKS, BY COUNTRY, 2019–2026 (USD MILLION)
9 MICROCARRIER MARKET, BY REGION (Page No. - 155)
9.1 INTRODUCTION
TABLE 167 MICROCARRIER MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: MICROCARRIER MARKET SNAPSHOT
TABLE 168 NORTH AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 169 NORTH AMERICA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 NORTH AMERICA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 171 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 172 NORTH AMERICA: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 174 NORTH AMERICA: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 175 NORTH AMERICA: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 NORTH AMERICA: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 177 NORTH AMERICA: MICROCARRIER MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US is a leading global market for microcarrier products
TABLE 178 US: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 179 US: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 US: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 181 US: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 182 US: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 183 US: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 US: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 185 US: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 US: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising government investment in stem cell research boosts the Canadian microcarriers market
TABLE 187 CANADA: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 188 CANADA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 189 CANADA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 CANADA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 191 CANADA: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 CANADA: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 193 CANADA: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 194 CANADA: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 195 CANADA: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 196 KEY PUBLIC EUROPEAN ADVANCED THERAPY COMPANIES
TABLE 197 EUROPE: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 198 EUROPE: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 199 EUROPE: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 EUROPE: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 201 EUROPE: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 202 EUROPE: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 203 EUROPE: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 204 EUROPE: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 205 EUROPE: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 206 EUROPE: MICROCARRIER MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany holds the largest share of the European microcarriers market
TABLE 207 GERMANY: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 208 GERMANY: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 209 GERMANY: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 GERMANY: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 211 GERMANY: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 212 GERMANY: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 213 GERMANY: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 214 GERMANY: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 GERMANY: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Increase in funding to boost R&D activities is projected to drive the growth of the French microcarriers market
TABLE 216 FRANCE: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 217 FRANCE: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 218 FRANCE: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 219 FRANCE: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 220 FRANCE: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 221 FRANCE: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 222 FRANCE: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 223 FRANCE: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 224 FRANCE: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 UK
9.3.3.1 Focus on cancer research funding will increase the demand for microcarriers in the UK
TABLE 225 UK: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 226 UK: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 227 UK: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 228 UK: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 229 UK: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 230 UK: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 231 UK: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 232 UK: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 233 UK: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Government support for life science research to fuel the adoption of microcarrier-based cell culture products in Italy
TABLE 234 ITALY: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 235 ITALY: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 236 ITALY: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 237 ITALY: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 238 ITALY: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 239 ITALY: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 240 ITALY: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 241 ITALY: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 242 ITALY: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Facility expansion and investment in bioprocessing technologies to aid market growth in Spain
TABLE 243 SPAIN: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 244 SPAIN: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 245 SPAIN: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 246 SPAIN: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 247 SPAIN: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 248 SPAIN: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 249 SPAIN: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 250 SPAIN: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 251 SPAIN: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 252 ROE: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 253 ROE: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 254 ROE: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 255 ROE: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 256 ROE: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 257 ROE: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 258 ROE: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 259 ROE: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 260 ROE: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 23 ASIA PACIFIC: MICROCARRIER MARKET SNAPSHOT
TABLE 261 APAC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 262 APAC: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 263 APAC: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 264 APAC: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 265 APAC: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 266 APAC: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 267 APAC: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 268 APAC: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 269 APAC: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 270 APAC: MICROCARRIER MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to register the highest growth in the Asia Pacific microcarriers market during the forecast period
TABLE 271 CHINA: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 272 CHINA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 273 CHINA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 274 CHINA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 275 CHINA: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 276 CHINA: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 277 CHINA: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 278 CHINA: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 279 CHINA: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Strategic developments by pharmaceutical companies to drive the market for microcarrier cell culture in Japan
TABLE 280 JAPAN: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 281 JAPAN: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 282 JAPAN: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 283 JAPAN: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 284 JAPAN: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 285 JAPAN: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 286 JAPAN: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 287 JAPAN: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 288 JAPAN: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Expansion of manufacturing facilities is likely to support the growth of the market in India
TABLE 289 INDIA: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 290 INDIA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 291 INDIA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 292 INDIA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 293 INDIA: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 294 INDIA: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 295 INDIA: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 296 INDIA: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 297 INDIA: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 298 ROAPAC: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 299 ROAPAC: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 300 ROAPAC: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 301 ROAPAC: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 302 ROAPAC: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 303 ROAPAC: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 304 ROAPAC: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 305 ROAPAC: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 306 ROAPAC: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 307 LATIN AMERICA: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 308 LATIN AMERICA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 309 LATIN AMERICA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 310 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 311 LATIN AMERICA: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 312 LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 313 LATIN AMERICA: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 314 LATIN AMERICA: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 315 LATIN AMERICA: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 316 LATIN AMERICA: MICROCARRIER MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil dominates the LATAM microcarriers market
TABLE 317 BRAZIL: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 318 BRAZIL: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 319 BRAZIL: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 320 BRAZIL: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 321 BRAZIL: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 322 BRAZIL: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 323 BRAZIL: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 324 BRAZIL: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 325 BRAZIL: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 REST OF LATIN AMERICA
TABLE 326 ROLA: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 327 ROLA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 328 ROLA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 329 ROLA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 330 ROLA: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 331 ROLA: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 332 ROLA: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 333 ROLA: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 334 ROLA: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 DEVELOPMENT AND COMMERCIALIZATION OF CELL AND GENE THERAPY IN MEA SUPPORTS THE MARKET GROWTH
TABLE 335 MEA: MICROCARRIER MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 336 MEA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 337 MEA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 338 MEA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 339 MEA: MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 340 MEA: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 341 MEA: MICROCARRIER MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 342 MEA: MICROCARRIER MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 343 MEA: MICROCARRIER MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 225)
10.1 OVERVIEW
10.2 MARKET EVALUATION FRAMEWORK
TABLE 344 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES, THE MAJOR STRATEGY ADOPTED BY PLAYERS
10.3 MARKET SHARE ANALYSIS
FIGURE 24 MICROCARRIER MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE
10.5.4 EMERGING COMPANIES
FIGURE 26 MICROCARRIERS MARKET: COMPANY EVALUATION QUADRANT, 2020
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 27 MICROCARRIERS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
10.7 COMPANY PRODUCT FOOTPRINT
TABLE 345 PRODUCT PORTFOLIO ANALYSIS: MICROCARRIERS MARKET (2020)
10.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 346 GEOGRAPHIC REVENUE MIX: MICROCARRIERS MARKET (2020)
10.9 COMPETITIVE SCENARIO
TABLE 347 MICROCARRIERS MARKET: PRODUCT LAUNCHES, JANUARY 2018–JANUARY 2021
TABLE 348 MICROCARRIERS MARKET: DEALS, JANUARY 2019–JANUARY 2021
TABLE 349 MICROCARRIERS MARKET: OTHER DEVELOPMENTS, JANUARY 2018–JANUARY 2021
11 COMPANY PROFILES (Page No. - 236)
11.1 KEY MARKET PLAYERS
(Business overview, Products offered, Recent developments, SWOT analysis, and MNM View)*
11.1.1 THERMO FISHER SCIENTIFIC
FIGURE 28 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
11.1.2 CORNING
FIGURE 29 CORNING: COMPANY SNAPSHOT
11.1.3 MERCK
FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT
11.1.4 SARTORIUS
FIGURE 31 SARTORIUS AG: COMPANY SNAPSHOT
11.1.5 DANAHER CORPORATION
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT
11.1.6 BECTON, DICKINSON AND COMPANY
FIGURE 33 BD: COMPANY SNAPSHOT
11.1.7 EPPENDORF AG
FIGURE 34 EPPENDORF: COMPANY SNAPSHOT
11.1.8 LONZA GROUP
FIGURE 35 LONZA GROUP AG: COMPANY SNAPSHOT
11.1.9 GETINGE AB
FIGURE 36 GETINGE AB: COMPANY SNAPSHOT
11.1.10 CHEMOMETEC
FIGURE 37 CHEMOMETEC A/S: COMPANY SNAPSHOT
11.1.11 CESCO BIOENGINEERING
11.1.12 HIMEDIA LABORATORIES
11.1.13 ESCO VACCIXCELL
11.2 OTHER PLAYERS
11.2.1 STEMCELL TECHNOLOGIES
11.2.2 SOLIDA BIOTECH
11.2.3 STOBBE PHARMA
11.2.4 DISTEK
11.2.5 CELLTAINER BIOTECH
11.2.6 G&G TECHNOLOGIES
11.2.7 TANTTI
*Details on Business overview, Products offered, Recent developments, SWOT analysis, and MNM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 285)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global microcarriers market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the microcarriers market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Data
The secondary sources referred to for this research study include publications from government sources, such as the American Society for Centers for Disease Control and Prevention (CDC), Food and Drug Administration, World Health Organization (WHO), American Cancer Society, National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), and Eurostat, among others. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations, among others. Secondary data was collected and analyzed to arrive at the overall size of the global microcarriers market, which was validated through primary research.
Primary Data
Extensive primary research was conducted after acquiring basic knowledge about the global microcarriers market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & biotechnology companies, academic & research institutes, and CROs/CMOs) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others from tier 1 and tier 2 companies engaged in offering prodyct in microcarriers market) across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Primary research was used in this report to:
- Validate the market segmentation defined through a product portfolio assessment of the leading players in the microcarriers market
- Understand key industry trends and issues defining the strategic growth objectives of market players
- Gather both demand- and supply-side validation of the key factors affecting the market growth (such as market drivers, restraints, and opportunities)
- Validate assumptions for the market sizing and forecasting model used for this study
- Understand the market position of leading players in the microcarriers market and their market shares/rankings
To know about the assumptions considered for the study, download the pdf brochure
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the microcarriers market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the microcarriers market
Report Objectives
- To define, describe, and forecast the global microcarriers market based on product, application, end user, and region.
- To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, and opportunities).
- To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall microcarriers market.
- To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders.
- To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To profile the key players and comprehensively analyze their market shares and core competencies.
- To track and analyze competitive developments such as new product launches; acquisitions; expansions; and partnerships, collaborations, and agreements
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the RoE microcarriers market, by country
- Further breakdown of the RoAPAC microcarriers market, by country
- Further breakdown of the Rest of Latin American and Middle Eastern & African microcarriers market, by country
Company Information
Detailed analysis and profiling of additional market players (up to 5) inclusive of:
- Business Overview
- Financial Information
- Product Offered
- Developments (Last three years)
Microcarrier Market & Its impact on Microcarrier Cell Culture Market
Microcarriers are small beads or particles used in biopharmaceutical production for the cultivation of anchorage-dependent cells such as animal or human cells. The microcarrier market is growing rapidly due to the increasing demand for cell-based therapies and the need for efficient cell culture systems.
The microcarrier market is expected to have a significant impact on the microcarrier cell culture market as it provides an efficient platform for the growth of anchorage-dependent cells. The microcarrier cell culture market is projected to witness substantial growth due to the increasing demand for cell-based therapies, rising investments in regenerative medicine, and the growing prevalence of chronic diseases.
Moreover, the use of microcarriers in cell culture allows for the expansion of cells in large quantities, which is crucial for the commercial production of biopharmaceuticals. Microcarriers also offer advantages such as easy scalability, reduced batch-to-batch variability, and improved cell viability and productivity, making them a preferred choice for cell culture applications.
In summary, the growing microcarrier market is expected to have a positive impact on the microcarrier cell culture market as it offers a reliable and efficient platform for cell-based therapy production. The development of new and advanced microcarrier technologies is likely to further boost the growth of the microcarrier cell culture market in the coming years.
Top Key players in the Microcarrier Cell Culture Market
The microcarrier cell culture market is highly competitive, with several leading players operating in the industry. Here are some of the top key players in the microcarrier cell culture market:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Danaher Corporation
- Corning Incorporated
- Sartorius AG
- Eppendorf AG
- Lonza Group AG
- Becton, Dickinson and Company
- HiMedia Laboratories
Industry impact of Microcarrier Cell Culture Market
The growth of the microcarrier cell culture market is expected to impact several key industries in various ways. Here are some of the industries that may be impacted by the growth of the microcarrier cell culture market:
Biopharmaceutical Industry: The biopharmaceutical industry is likely to be the primary beneficiary of the growth of the microcarrier cell culture market. The use of microcarriers in cell culture provides a more efficient platform for the production of biopharmaceuticals, which are increasingly being used in the treatment of various diseases.
Regenerative Medicine Industry: The regenerative medicine industry is also likely to benefit from the growth of the microcarrier cell culture market. The use of microcarriers in cell culture can facilitate the production of cells and tissues for regenerative medicine applications.
Research and Development (R&D) Industry: The R&D industry may also be impacted by the growth of the microcarrier cell culture market. The development of new and advanced microcarrier technologies can enable more efficient and cost-effective cell culture systems, which can accelerate the pace of research and development in various fields.
Academic and Research Institutions: Academic and research institutions that conduct research in the field of biotechnology, biopharmaceuticals, and regenerative medicine may also benefit from the growth of the microcarrier cell culture market. The availability of more efficient and advanced cell culture systems can enhance their research capabilities and facilitate new discoveries.
Contract Research Organizations (CROs): Contract research organizations that provide research and development services to the biopharmaceutical and regenerative medicine industries may also be impacted by the growth of the microcarrier cell culture market. The demand for contract research services is likely to increase as the industry grows, creating new opportunities for CROs.
Futuristic Growth opportunities in the Microcarrier Cell Culture Market
3D Cell Culture: The use of microcarriers in 3D cell culture systems can provide a more physiologically relevant environment for cells, which can enhance their growth and function. The development of advanced microcarrier technologies that can support 3D cell culture is likely to create new growth opportunities in the microcarrier cell culture market.
Single-Use Microcarriers: The demand for single-use microcarriers is increasing due to their ease of use, reduced risk of contamination, and cost-effectiveness. The development of advanced single-use microcarrier technologies that can support large-scale cell culture is likely to create new growth opportunities in the microcarrier cell culture market.
Stem Cell Culture: The use of microcarriers in stem cell culture is gaining traction due to their ability to support the growth and differentiation of stem cells. The development of advanced microcarrier technologies that can support the culture of different types of stem cells is likely to create new growth opportunities in the microcarrier cell culture market.
Emerging Markets: The microcarrier cell culture market is expanding globally, with increasing demand from emerging markets such as Asia Pacific and Latin America. The development of microcarrier technologies that can cater to the specific needs of these markets is likely to create new growth opportunities in the microcarrier cell culture market.
Personalized Medicine: The development of personalized cell-based therapies is gaining traction, driven by advances in genomics and biotechnology. The use of microcarriers in personalized medicine is likely to create new growth opportunities in the microcarrier cell culture market, as the production of personalized therapies requires efficient and scalable cell culture systems.
Growth opportunities and latent adjacency in Microcarrier Market
Which segment to dominate the global as well as regional Microcarrier Market?
What are the key technological trends in Microcarrier Market?
What will be the future trends in global Microcarrier Market?